Tailoring tacrolimus-based immunotherapy in renal transplantation

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 1, 2003, Pages

  Yang, Harold C ^a  

^a Pinnacle Health System   (United States)

Author keywords

Graft survival; Kidney transplantation; Mycophenolate mofetil; Renal graft function; Sirolimus; Tacrolimus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE KIDNEY FUNCTION RELATION; DRUG EFFICACY; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LONG TERM CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

CLINICAL TRIALS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; KIDNEY TRANSPLANTATION; TACROLIMUS;

EID: 0037670166     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612
2. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590
3. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318
4. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697-1701
5. Cecka MJ. The UNOS Scientific Renal Transplant Registry. In: Cecka MJ, Terasaki PI, eds, Clinical Transplants. UCLA Tissue Typing Laboratory, Los Angeles: 1998; 1-16
6. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983
7. Margreiter R, for the European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359: 741-746
8. Sollinger HW, for the US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-232
9. Kahan BD for The Rapamune US Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 2000; 356: 194-202
10. Johnson C, Ahsan N, Gonwa T et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834-841
11. Ahsan N, Johnson C, Gonwa T et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation 2001; 72: 245-250
12. Halloran P, Ahsan N, Johnson C et al. Three year follow up of a randomized multicenter kidney transplant study comparing tacrolimus (TAC)+azathioprine (AZA) vs cyclosporine modified (CSA)+mycophenolate mofetil (MMF) vs TAC+MMF. Am J Transplant 2001; 1 (Suppl): 405 (Abstract 1070)
13. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002; 62: 1848-1854
14. Squifflet J-P, Bäckman L, Claesson K et al. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. Transplantation 2001; 72: 63-69
15. van Hooff JP, Squifflet J-P, Vanrenterghem Y. Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results. Transplant Proc 2002; 34: 1591-1593